In addition to their ability to promote the release of CCL2 and CCL5 by the tumor cells, it is possible that TNFα and IL-1β act directly to elevate processes that are required for local recurrence or metastasis formation, which identify the IDC-with-relapse group of patients. The gene discussed is TNF; the disease is neoplasm.